GSK598809 is a selective D(3)R antagonist recently progressed in Phase I trials. GSK-598809 may decrease the rewarding effects of contextual cues associated with drug intake preclinically, which may reduce drug craving in humans.
Molecular Weight:
495.54
CAS Number:
[1310803-30-5]
Formula:
C23H25F4N5OS
Target:
Others
T71001
* VAT and and shipping costs not included. Errors and price changes excepted